Over the past 26 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all our stakeholders on the other - especially the patients and their families as well as also the doctors and care professionals treating them.
Die AOP Orphan Pharmaceuticals Deutschland GmbH am Standort Ismaning ist ein 100%iges Tochterunternehmen der AOP Orphan AG, ein österreichisches Pharmaunternehmen mit Sitz in Wien. Der Fokus des Geschäftsmodells liegt auf dem Gesundheitsmarkt, wobei im Zentrum der Geschäftsaktivitäten hochwertige Markenpräparate für seltene und komplexe Erkrankungen stehen. Als aufstrebendes Unternehmen fühlen wir uns in erster Linie dem medizinischen Erfolg gegenüber dem Patienten verpflichtet.
Needs. Science. Trust. The international healthcare group focuses on research, development and global sales of innovative treatment solutions. AOP Health believes it has a responsibility to make innovative integrated therapies and disease-management solutions available long term to as many patients as possible who suffer from rare diseases or require critical care.
Needs. Science. Trust.
The international healthcare group focuses on research, development and global sales of innovative treatment solutions. AOP Health believes it has a responsibility to make innovative integrated therapies and disease-management solutions available long term to as many patients as possible who suffer from rare diseases or require critical care.
Data protection information: https://www.aop-health.com/global_en/footer/privacy-policy
We at AOP Health focus on rare and complex diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders and Critical Care. Our strategic goal at AOP Health is to constantly deliver new treatment options for the patients with rare disease and in critical care. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.
Der deutsche Markt und die Vertriebsgesellschaft wachsen sehr stark und in Zusammenarbeit mit Österreich bietet das Unternehmen langfristige Perspektiven.
More about: www.aop-health.de
Over the past 26 years, the AOP Health Group has become an established and international provider of integrated therapy solutions from its headquarters in Vienna.
Based on its research-centered approach, AOP Health has a profound understanding of rare diseases and critical care. Therefore, the company has been able to position itself as an innovative front-runner in the development of effective therapies and drugs.